Stay updated on Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Minor version update: Revision 3.4.2 replaces 3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:32:18.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0, indicating a minor maintenance/version update. This appears to be a non-content change with no visible impact on core information or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T15:43:28.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A minor metadata update shows Revision: v3.3.4 added and Revision: v3.3.3 removed in the Study Documents section. This change does not affect the study content, results, eligibility criteria, or overall purpose of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:13:40.000Z thumbnail image
  5. Check
    69 days ago
    Change Detected
    Summary
    Footer updates: added 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.1%
    Check dated 2025-12-17T17:47:33.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    Publication descriptions were updated to clarify that listed publications are provided voluntarily and are automatically filled from PubMed, and a new revision tag v3.3.2 was added.
    Difference
    0.2%
    Check dated 2025-11-26T07:40:50.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page, eliminating the banner that previously directed users to opm.gov for status updates.
    Difference
    0.4%
    Check dated 2025-11-19T08:26:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.